Status:
COMPLETED
Performance of an Ultrasensible Malaria Rapid Diagnostic Test Among Pregnant Women in Burkina Faso
Lead Sponsor:
Centre MURAZ/Institut National de Santé Publique
Collaborating Sponsors:
University of Ghana
Conditions:
Malaria,Falciparum
Eligibility:
FEMALE
Brief Summary
The goal of this observational study is to learn about the diagnostic performance of the highly sensitive rapid diagnostic test (HS-RDT) compared to an ultrasensitive qPCR for detection of falciparum ...
Detailed Description
A cross-sectional study including 288 pregnant women was conducted at the Centre médical urbain (CMU) of Lafiabougou located in the periurban area of Bobo-Dioulasso the second largest city of Burkina ...
Eligibility Criteria
Inclusion
- Living in Bobo-Dioulasso for at least 6 months before the beginning of the study ;
- Provision of informed consent.
Exclusion
- Past history of malaria or antimalarial drugs within the last 3 months ;
- Having tested positive for malaria by microscopy or RDT in any previous ANC visit ;
- Symptoms and signs of severe malaria as defined by WHO.
Key Trial Info
Start Date :
October 11 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2023
Estimated Enrollment :
288 Patients enrolled
Trial Details
Trial ID
NCT06572644
Start Date
October 11 2022
End Date
December 31 2023
Last Update
August 28 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Médical Urbain de Lafiabougou
Bobo-Dioulasso, Houet, Burkina Faso, 390